Stella, F., Schneider, M., Paruzzo, L., Noll, J. H., Devi, P., Babatunde, V., Chong, E., Ho, M., Thomas, C., Cook, M., Hossain, N., Carter, J., Li, Z., Tan, M., Michener, P., Guruprasad, P., Patel, V., Imparato, A., Carturan, A., Lemoine, J., Souza, V., Porazzi, P., Fraietta, J., Barta, S., Nasta, S. D., Svoboda, J., Schuster, S. J., Maillard, I., Landsburg, D., Ruella, M. (2025). Naive CD4+ at apheresis and disease control at infusion are associated with improved efficacy in second-line CAR T-cells. Blood. https://doi.org/10.1182/blood-2025-2755